U.S. flag

An official website of the United States government

NM_183050.4(BCKDHB):c.392G>T (p.Gly131Val) AND Maple syrup urine disease

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Apr 5, 2024
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001918259.5

Allele description [Variation Report for NM_183050.4(BCKDHB):c.392G>T (p.Gly131Val)]

NM_183050.4(BCKDHB):c.392G>T (p.Gly131Val)

Gene:
BCKDHB:branched chain keto acid dehydrogenase E1 subunit beta [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
6q14.1
Genomic location:
Preferred name:
NM_183050.4(BCKDHB):c.392G>T (p.Gly131Val)
HGVS:
  • NC_000006.12:g.80167726G>T
  • NG_009775.2:g.66100G>T
  • NM_000056.5:c.392G>T
  • NM_001318975.1:c.182G>T
  • NM_183050.3:c.392G>T
  • NM_183050.4:c.392G>TMANE SELECT
  • NP_000047.1:p.Gly131Val
  • NP_001305904.1:p.Gly61Val
  • NP_898871.1:p.Gly131Val
  • NC_000006.11:g.80877443G>T
  • NM_183050.4:c.392G>T
  • NR_134945.2:n.415G>T
Protein change:
G131V
Links:
dbSNP: rs774472182
NCBI 1000 Genomes Browser:
rs774472182
Molecular consequence:
  • NM_000056.5:c.392G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001318975.1:c.182G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_183050.4:c.392G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NR_134945.2:n.415G>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Maple syrup urine disease (MSUD)
Identifiers:
MONDO: MONDO:0009563; MeSH: D008375; MedGen: C0024776; Orphanet: 511; OMIM: PS248600

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002179705Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Oct 24, 2022)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

SCV005077384Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Pathogenic
(Apr 5, 2024)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

A Novel Whole Gene Deletion of BCKDHB by Alu-Mediated Non-allelic Recombination in a Chinese Patient With Maple Syrup Urine Disease.

Liu G, Ma D, Hu P, Wang W, Luo C, Wang Y, Sun Y, Zhang J, Jiang T, Xu Z.

Front Genet. 2018;9:145. doi: 10.3389/fgene.2018.00145.

PubMed [citation]
PMID:
29740478
PMCID:
PMC5928131

Identification of eight novel mutations in 11 Chinese patients with maple syrup urine disease.

Sun WH, Wu BB, Wang YQ, Wu MY, Dong XR, Zhang YP, Lu W, Zhang P, Yang B, Zhang M, Wu HJ, Zhou WH.

World J Pediatr. 2020 Aug;16(4):401-410. doi: 10.1007/s12519-020-00349-1. Epub 2020 Mar 19.

PubMed [citation]
PMID:
32193832
See all PubMed Citations (6)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002179705.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Gly131 amino acid residue in BCKDHB. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 29740478, 32193832). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt BCKDHB protein function. ClinVar contains an entry for this variant (Variation ID: 1407094). This missense change has been observed in individual(s) with maple syrup urine disease (PMID: 31980395, 33955723). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glycine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 131 of the BCKDHB protein (p.Gly131Val).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV005077384.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

Variant summary: BCKDHB c.392G>T (p.Gly131Val) results in a non-conservative amino acid change located in the Transketolase-like, pyrimidine-binding domain (IPR005475) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251182 control chromosomes. c.392G>T has been reported in the literature in multiple homozygous and compound heterozygous individuals affected with classic Maple Syrup Urine Disease (e.g. Strauss_2020, Margutti_2020, Campanholi_2021). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 33955723, 33131499, 31980395). ClinVar contains an entry for this variant (Variation ID: 1407094). Based on the evidence outlined above, the variant was classified as pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024